Patents by Inventor David Radunsky

David Radunsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8597516
    Abstract: The present invention relates to a method and system for using a very large pore hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: December 3, 2013
    Assignee: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Publication number: 20110040228
    Abstract: The present invention relates to a method and system for using a very large pore hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Application
    Filed: October 28, 2010
    Publication date: February 17, 2011
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Patent number: 7837878
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: November 23, 2010
    Assignee: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Publication number: 20090204050
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Application
    Filed: April 17, 2009
    Publication date: August 13, 2009
    Applicant: IMMUNOCEPT, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Patent number: 7524420
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood. The replacement fluid may include pharmaceutical grade balanced salt solution containing albumin and/or other target receptor molecules and/or other physiological molecules in a sufficient concentration to adequately replenish ongoing losses.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: April 28, 2009
    Assignee: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Patent number: 7520992
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: April 21, 2009
    Assignee: Imunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Publication number: 20060163138
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Application
    Filed: March 23, 2006
    Publication date: July 27, 2006
    Inventors: David Radunsky, James Matson, Patrice Lee
  • Publication number: 20040173530
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Application
    Filed: March 8, 2004
    Publication date: September 9, 2004
    Applicant: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Patent number: 6787040
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: September 7, 2004
    Assignee: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee
  • Publication number: 20040060866
    Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
    Type: Application
    Filed: May 15, 2001
    Publication date: April 1, 2004
    Applicant: Immunocept, L.L.C.
    Inventors: David Radunsky, James R. Matson, Patrice A. Lee